Shelby K. Wyatt

Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells

Todd W. Miller, James T. Forbes, Chirayu Shah et al. · Clinical Cancer Research · 2009 · 131 citations · Full text

Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex

Ganesh Kolumam, Mark Z. Chen, Raymond K. Tong et al. · EBioMedicine · 2015 · 107 citations · Full text

Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer

H. Charles Manning, Nipun B. Merchant, A. Coe Foutch et al. · Clinical Cancer Research · 2008 · 104 citations · Full text

Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer

Chirayu Shah, Todd W. Miller, Shelby K. Wyatt et al. · Clinical Cancer Research · 2009 · 84 citations · Full text

Blocking NRG1 and Other Ligand-Mediated Her4 Signaling Enhances the Magnitude and Duration of the Chemotherapeutic Response of Non–Small Cell Lung Cancer

Ganapati V. Hegde, Cecile C. de la Cruz, Cecilia Chiu et al. · Science Translational Medicine · 2013 · 83 citations